Is the problem of intact coronary arteries still or is it close to solving?
https://doi.org/10.15829/1560-4071-2021-4139
Abstract
The dominant paradigm in the diagnosis of patients with stable coronary artery disease was the identification of patients with obstructive lesions of the coronary arteries, and then - ensuring the possibility of myocardial revascularization. The diagnostic algorithms used until recently led to the fact that in invasive coronary angiography obstructive changes in the coronary arteries were detected in less than half of the cases. In the 2019 European Guidelines for the Diagnosis of Chronic Coronary Syndrome, this algorithm was significantly revised, but the results of its implementation have not yet been published. Currently, several pathophysiological variants of angina pectoris have been proposed, which can be identified by an interventional diagnostic procedure for invasive coronary angiography. Recent studies have shown that up to 90% of patients without obstructive lesions of the epicardial coronary arteries have microvascular or vasospastic angina. This review focuses on these topical aspects of the problem of intact coronary arteries.
About the Author
A. N. Sumin
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Alexey N. Sumin - laboratory of comorbidity in cardiovascular diseases, head
Kemerovo
References
1. Neumann FJ, Sousa-Uva M, Ahlsson A, et al.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394.
2. Ganyukov VI, Protopopov AV, Bashkireva AL, et al. European initiative “Stent for life” in Russia. Russ J Cardiol. 2016;6:68-72. (In Russ.) doi:10.15829/1560-4071-2016-6-68-72.
3. Knuuti J, Wijns W, Saraste A, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. doi:10.1093/eurheartj/ehz425.
4. Smeeth L, Skinner JS, Ashcroft J, et al.; Chest Pain Guideline Development Group. NICE clinical guideline: chest pain of recent onset. Br J Gen Pract. 2010;60(577):607-10. doi:10.3399/bjgp10X515124.
5. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44-e164. doi:10.1016/j.jacc.2012.07.013.
6. Montalescot G, Sechtem U, Achenbach S, et al. Task Force Members. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003. doi:10.1093/eurheartj/eht296.
7. Timmis A, Roobottom CA. National Institute for Health and Care Excellence updates the stable chest pain guideline with radical changes to the diagnostic paradigm. Heart. 2017;103(13):982-6. doi:10.1136/heartjnl-2015-308341.
8. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886-95. doi:10.1056/NEJMoa0907272.
9. Rio P, Ramos R, Pereira-da-Silva T, et al. Yield of contemporary clinical strategies to detect patients with obstructive coronary artery disease. Heart Int. 2016;10(1):e12-9. doi:10.5301/heartint.5000224.
10. Korok EV, Sumin AN, Sinkov MA, et al. The prevalence of intact coronary arteries in relation with indications for scheduled coronary arteriography. Russ J Cardiol. 2016;2:52-9. (In Russ.) doi:10.15829/15604071-2016-2-52-59.
11. Douglas PS, De Bruyne B, Pontone G, et al.; PLATFORM Investigators. 1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study. J Am Coll Cardiol. 2016;68(5):435-45. doi:10.1016/j.jacc.2016.05.057.
12. Alekyan BG, Grigor’yan AM, Staferov AV, Karapetyan NG. Endovascular diagnostics and treatment in the Russian Federation (2017). Endovaskulyarnaya hirurgiya. 2018;2:93-240. (In Russ.) doi:10.24183/24094080-2018-5-2-93-240.
13. Tashakkor AY, Stone J, Mancini GB. Is it time to update how suspected angina is evaluated prior to the use of specialized tests implications based on a systematic review. Cardiology. 2016;133(3):181-90. doi:10.1159/000441562.
14. Sumin AN, Korok EV, Heraskov VYu, Barbarash OL. Diagnostics of stable coronary artery disease: the problem of intact coronary arteries. Kardiologicheskij vestnik. 2018;13(3):46-51. (In Russ.) doi:10.17116/Cardiobulletin20181303146.
15. Baskaran L, Danad I, Gransar H, et al. A Comparison of the Updated DiamondForrester, CAD Consortium, and CONFIRM History-Based Risk Scores for Predicting Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: The SCOT-HEART Coronary CTA Cohort. JACC Cardiovasc Imaging. 2019;12(7Pt2):1392-400. doi:10.1016/j. jcmg.2018.02.020.
16. Sumin AN. The assessment of pretest probability in obstructive coronary lesion diagnostics: unresolved issues. Russ J Cardiol. 2017;11:68-76. (In Russ.) doi:10.15829/1560-4071-2017-11-68-76.
17. Korok EV, Sumin AN. Current issues of CHD diagnosis in materials of the russian cardiology congress (Ekaterinburg, 20-23 September 2016). Complex Issues of Cardiovascular Diseases. 2017;(1):131-40. (In Russ.) doi:10.17802/2306-1278-2017-1-131-140.
18. Asher A, Ghelani R, Thornton G, et al. UK perspective on the changing landscape of non-invasive cardiac testing. Open Heart. 2019;6(2):e001186. doi:10.1136/openhrt-2019-001186.
19. Fyyaz S, Hudson J, Olabintan O, et al. Computed tomography coronary angiography: Diagnostic yield and downstream testing. Clin Med (Lond). 2020;20(1):81-5. doi:10.7861/clinmed.2019-0139.
20. Sumin AN. A New Diagnostic Algorithm for Examining Patients with Suspected Chronic Coronary Syndrome: Questions Remain? Rational Pharmacotherapy in Cardiology. 2020;16(3):474-80. (In Russ.) doi:10.20996/1819-6446 2020-06-14.
21. Ford TJ, Berry C. Angina: contemporary diagnosis and management. Heart. 2020;106(5):387-98. doi:10.1136/heartjnl-2018-314661.
22. Ford TJ, Ong P, Sechtem U, et al.; COVADIS Study Group. Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When. JACC Cardiovasc Interv. 2020;13(16):1847-64. doi:10.1016/j.jcin.2020.05.052.
23. Maron DJ, Hochman JS, Reynolds HR, et al.; ISCHEMIA Research Group. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382(15):1395407. doi:10.1056/NEJMoa1915922.
24. Ford TJ, Stanley B, Good R, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol. 2018;72(23 Pt A):284155. doi:10.1016/j.jacc.2018.09.006.
25. Ford TJ, Stanley B, Sidik N, et al. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA). JACC Cardiovasc Interv. 2020;13(1):3345. doi:10.1016/j.jcin.2019.11.001.
26. Terpenning S, Stillman A. Cost-effectiveness for imaging stable ischemic disease. Br J Radiol. 2020;93(1113):20190764. doi:10.1259/bjr.20190764.
27. Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017;135(11):1075-92. doi:10.1161/CIRCULATIONAHA.116.024534.
Supplementary files
Review
For citations:
Sumin A.N. Is the problem of intact coronary arteries still or is it close to solving? Russian Journal of Cardiology. 2021;26(2):4139. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4139
Views:
2651
Email this article 